A Bayesian model for evaluating specificity of treatment effects in clinical trials
Cancer Treat Res
.
1995:75:155-75.
doi: 10.1007/978-1-4615-2009-2_8.
Authors
R M Simon
1
,
D O Dixon
,
B Freidlin
Affiliation
1
Biometrics Research Branch, National Cancer Institute (NCI), Bethesda, MD 20892, USA.
PMID:
7640162
DOI:
10.1007/978-1-4615-2009-2_8
No abstract available
Publication types
Research Support, U.S. Gov't, P.H.S.
Review
MeSH terms
Acquired Immunodeficiency Syndrome / drug therapy
Bayes Theorem*
Clinical Trials as Topic*
Humans
Proportional Hazards Models